Expressions of stemness markers in keloid tissue

Sri S. Ningsih, Dewi H. Sari, Radiana D. Antarianto, Novi S. Hardiany, Mohamad Sadikin, Septelia I. Wanandi, Sri W.A. Jusman



Background: Keloid is an abnormal wound healing process that extends beyond the site of injury. Keloid and tumor’s shared similarity of recurrence suggesting a shared underlying mechanism that involves stemness. Octamer-binding transcription factor-4 (Oct-4) and aldehyde dehydrogenase-1 (ALDH1) are stem cell stemness markers. This study aimed to analyze Oct-4 and ALDH1 expressions in keloid tissues.

Methods: Samples were obtained from keloid tissue excisions from three keloid patients and post-circumcision preputial skin from three healthy donors (normal control) in accordance with the local ethical committee regulation. Total RNA was isolated using TriPure Isolation kit (Ameritech), and expressions of Oct4 and ALDH1 mRNA in keloid and preputial skin were determined by quantitative reverse transcription–polymerase chain reaction (qRT-PCR) using Livak method.

Results: The qRT-PCR analysis revealed the expressions of Oct4 and ALDH1 in keloid and preputial skin tissues. Keloid tissues exhibited lower expression levels of Oct-4 and ALDH1 than the preputial skin. The difference was statistically insignificant.

Conclusion: Keloid tissues express Oct-4 and ALDH1 as stemness markers, and the stemness characteristics of keloid might be similar to a normal skin.


ALDH1, keloid, Oct-4, stemness

Full Text:



  1. Goder M, Kornhaber R, Bordoni D, Winkler E, Haik J, Tessone A. Cutaneous basal cell carcinoma arising within a keloid scar: a case report. Onco Targets Ther. 2016;9:4793–6.
  2. Ma X, Chen J, Xu B, Long X, Qin H, Zhao RC, et al. Keloid-derived keratinocytes acquire a fibroblast-like appearance and an enhanced invasive capacity in a hypoxic microenvironment in vitro. Int J Mol Med. 2015;35(5):1246–56.
  3. Zhang Q, Yidi W, Ann DK, Messadi DV, Tuan T, Kelly AP, et al. Mechanisms of hypoxic regulation of plasminogen activator inhibitor-1 gene expression in keloid fibroblasts. J Invest Dermatol. 2003;121(5):1005–12.
  4. Zeineddine D, Hammoud AA, Mortada M, Boeuf H. The Oct4 protein: more than a magic stemness marker. Am J Stem Cells. 2014;3(2):74–82.
  5. Samardzija C, Michael Q, Jock KF, Nuzhat A. Attributes of Oct4 in stem cell biology: perspectives on cancer stem cells of the ovary. J Ovarian Res. 2012;5(1):37–42.
  6. Deng C, Wang B, Zhang Z, Sun G, Zhu J, Wang D, et al. The expressions of notch genes in human keloid-derived mesenchymal-like stem cells. Zhonghua Zheng Xing Wai Ke Za Zhi. 2014;30(3):197–202.
  7. Grant C, Chudakova DA, Itinteang T, Chibnall AM, Brasch HD, Davis PF, et al. Expression of embryonic stem cell markers in keloid-associated lymphoid tissue. J Clin Pathol. 2016;69(7):643–6.
  8. Douville J, Beaulieu R, Balicki D. ALDH1 as a functional marker of cancer stem and progenitor cells. Stem Cells Dev. 2009;18(1):17–26.
  9. Lohberger B, Beate R, Nicole S, Markus A, Bernadette LA, Sonja MW, et al. Aldehyde dehydrogenase 1, a potential marker for cancer stem cells in human sarcoma. PLoS One. 2012;7(8):1–10.
  10. Hahn JM, Glaser K, McFarland KL, Aronow BJ, Boyce ST, Supp DM. Keloid-derived keratinocytes exhibit an abnormal gene expression profile consistent with a distinct causal role in keloid pathology. Wound Repair Regen. 2013;21(4):530–44.
  11. Battula VL, Evans KW, Hollier BG, Shi Y, Marini FC, Ayyanan A, et al. Epithelial-mesenchymal transition-derived cells exhibit multilineage differentiation potential similar to mesenchymal stem cells. Stem Cells. 2010;28(8):1435–45.
  12. Samardzija C, Quinn M, Findlay JK, Ahmed N. Attributes of Oct4 in stem cell biology: perspectives on cancer stem cells of the ovary. J Ovarian Res. 2012;5(37):1–12.
  13. Nakahata K, Shuichiro U, Shimpei N, Miyoko K, Masahiro Z, Takaharu O, et al. Aldehyde dehydrogenase 1 (ALDH1) is a potential marker for cancer stem cells in embryonal rhabdomyosarcoma. PLoS One. 2015;10(4):1–16.
  14. Jumper N, Hodgkinson T, Paus R, Bayat A. Site-specific gene expression profiling as a novel strategy for unravelling keloid disease pathobiology. PLoS One. 2017;12(3):1–33.
  15. Yan L, Rui C, Yuan BL, Lian ZW, Bo P, Xiao YL, et al. MiR-21-5p links epithelial-mMesenchymal transition phenotype with stem-like cell signatures via AKT signaling in keloid keratinocytes. Sci Rep. 2016;6:28281.
  16. Wang DL, Zhu JJ, Deng CL, Wang B, Yu LM. Identification of biological characteristics of human keloid-derived stem cells. Zhonghua Shao Shang Za Zhi. 2011;27(3):210–4.
  17. Rodemann HP, Rennekampff HO. Functional diversity of fibroblast. In: Mueller MM, Fusenig NE editors. Tumor-associated fibroblast and their matrix. New York: Springer; 2014. P.23-36.
  18. Chipev, Simman R, Hatch G, Katz AE, Siegel DM, Simon M. Myofibroblast phenotype and apoptosis in keloid and palmar fibroblasts invitro. Cell Death Differ. 2000;7:166–76.
  19. Wulandari E, Jusman SW, Moenadjat Y, Jusuf AA, Sadikin M. Expressions of collagen I and III in hypoxic keloid tissue. Kobe J Med Sci. 2016;62(3):E58–69.

Copyright (c) 2018 Sri S. Ningsih, Dewi H. Sari, Radiana D. Antarianto, Novi S. Hardiany, Mohamad Sadikin, Septelia I. Wanandi, Sri W.A. Jusman

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

All articles and issues in Medical Journal of Indonesia have unique DOI number registered in Crossref.
Unique Visitors